Nomination Committee for Vimian’s 2025 Annual General Meeting

Regulatory press release
Oct 11 2024

Nomination Committee for Vimian’s 2025 Annual General Meeting

The Nomination Committee for Vimian Group has been appointed.

Vimian’s Nomination Committee for the 2025 Annual General Meeting has been appointed based on the ownership structure as of September 30, 2024.

The Nomination Committee comprises the following members:

Håkan Håkansson, Fidelio Capital

Suzanne Sandler, Handelsbanken Fonder

Caroline Sjösten, Swedbank Robur Fonder

Magnus Welander, Chairman of the Board

Chairman of the Nomination Committee will be appointed at the Nomination Committee’s first meeting.

The Annual General Meeting of Vimian Group will be held on 29 April 2025. Shareholders who would like to submit proposals to the Nomination Committee for the 2025 Annual General Meeting can submit such via email to generalmeetings@vimian.com no later than 6 March 2025.

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 15,000 veterinary clinics and 1,700 labs, sells to over 80 markets, has 1,100 employees and annual revenues of approximately EUR 330 million. For more information, please visit: www.vimian.com. FNCA Sweden AB is appointed the Company’s Certified Adviser.